Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: Evidence for a role for insulin-like growth factor I

Journal of Clinical Investigation

Volumn 98, Issue 1, 1996, Pages 116-124

  Hirschberg, Raimund ^a  

^a HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

glomerular ultrafiltrate; insulin like growth factor I; insulin like growth factor binding proteins; interstitial fibrosis; nephrotic syndrome

Indexed keywords

ALBUMIN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; DOXORUBICIN; DRUG METABOLITE; NEUTRALIZING ANTIBODY; RECOMBINANT SOMATOMEDIN C; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOPHOSPHORYLATION; CONTROLLED STUDY; DRUG ACTIVITY; GLOMERULUS FILTRATION; HISTOPATHOLOGY; IMMUNOREGULATION; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY FIBROSIS; MALE; NEPHROTIC SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEINURIA; RAT; RECEPTOR BINDING; ULTRAFILTRATION;

EID: 0030035425     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118755     Document Type: Article

References (51)

1. Klahr, S., A.S. Levey, G.J. Beck, A.W. Caggiula, L. Hunsicker, J.W. Kusek, and G. Striker. 1994. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group. N. Engl. J. Med. 330:877-884.
2. Jackle, I., W. Gunther, H. von Gise, J.M. Alt, A. Bohle, and H. Stolte. 1988. Kidney function and protein excretion in relation to pathomorphology of glomerular diseases. Contrib. Nephrol. 68:128-135.
3. Bertani, T., F. Cutillo, C. Zoja, M. Broggini, and G. Remuzzi. 1986. Tubulo-interstitial lesions mediate renal damage in adriamycin glomerulopathy. Kidney Int. 30:488-496.
4. Hirschberg, R., and G.A. Kaysen. 1995. Insulin-like growth factor I and its binding proteins in the experimental nephrotic syndrome. Endocrinology. 136:1565-1571.
5. Gargosky, S.E., T. Hasegawa, P. Tapanainen, M. MacGillivray, Y. Hasegawa, and R.G. Rosenfeld. 1993. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease. J. Clin. Endocrinol. & Metab. 76:1631-1637.
6. Garin, E., M. Grant, and J. Silverstein. 1989. Insulin-like growth factors in patients with active nephrolic syndrome. Am. J. Dis. Child. 143:865-867.
7. Jones, J.I., and D.R. Clemmons. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocr. Rev. 16:3-34.
8. Feld, S., R. Hirschberg, A. Artishevsky, C. Nast, and S. Adler. 1995. Insulin-like growth factor I induces mesangial proliferation and increases mRNA and secretion of collagen. Kidney Int. 48:45-51.
9. Haverty, T.P., C.J. Kelly, W.H. Hines, P.S. Amenta, M. Watanabe, R.A. Harper, N.A. Kefalides, and E.G. Neilson. 1988. Characterization of a renal tubular epithelial cell line which secretes the autologous target antigen of autoimmune experimental interstitial nephritis. J. Cell Biol. 107:1359-1368.
10. Humes, H.D., T.F. Seals, D.A. Cieslinski, I.O. Sanchez, and T.P. Page. 1991. Effects of transforming growth factor-beta, transforming growth factor-alpha, and other growth factors on renal proximal tubule cells. Lab. Invest. 64: 538-545.
11. Ding, H., J.D. Kopple, A. Cohen, and R. Hirschberg. 1993. Recombinant human insulin-like growth factor-I accelerates recovery and reduces catabolism in rats with ischemic acute renal failure. J. Clin. Invest. 91:2281-2287.
12. Hammerman, M.R., and S. Rogers. 1987. Distribution of IGF receptors in the plasma membrane of proximal tubular cells. Am. J. Physiol. 253:841-847.
13. Hirschberg, R., H. Ding, and C. Wanner. 1995. Effects of insulin-like growth factor I on phosphate transport in cultured proximal tubule cells. J. Lab. Clin. Med. 126:428-434.
14. Quigley, R., and M. Baum. 1991. Effects of growth hormone and insulin-like growth factor I on rabbit proximal convoluted tubule transport. J. Clin. Invest. 88:368-374.
15. Baxter, R., and J. Martin. 1989. Structure of the Mr 140,000 growth hormone-dependent insulin-like growth factor binding protein complex: determination by reconstitution and affinity-labeling. Proc. Natl. Acad. Sci. USA. 86: 6898-6902.
16. Holly, J. 1993. Insulin-like growth factor binding proteins in diabetic and non-diabetic states. In Growth hormone and insulin-like growth factor I in human and experimental diabetes. A. Flyvbjerg, H. Orskov, and K. Alberti, editors. John Wiley & Sons Inc., Chichester, UK. 47-76.
17. Frystyk, J., C. Skjaerbaek, B. Dinesen, and H. Orskov. 1994. Free insulin like growth factor (IGF-I and IGF-II) in human serum. FEBS Lett. 348:185-191.
18. Remuzzi, A., R. Pergolizzi, M.S. Mauer, and T. Bertani. 1990. Three-dimensional morphometric analysis of segmental glomerulosclerosis in the rat. Kidney Int. 38:851-856.
19. Hirschberg, R., J.D. Kopple, R.C. Blantz, and B.J. Tucker. 1991. Effects of recombinant human insulin-like growth factor I on glomerular dynamics in the rat. J. Clin. Invest. 87:1200-1206.
20. Hirschberg, R., and J.D. Kopple. 1992. The growth hormone-insulin-like growth factor I axis and renal glomerular function. J. Am. Soc. Nephrol. 2: 1417-1422.
21. Hirschberg, R. 1993. Effects of growth hormone and IGF-I on glomerular ultrafiltration in growth hormone-deficient rats. Regul. Pept. 48:241-250.
22. Hirschberg, R., G. Brunori, J.D. Kopple, and H.P. Guler. 1993. Effects of insulin-like growth factor I on renal function in normal men. Kidney Int. 43: 387-397.
23. Furlanetto, R.W., L.E. Underwood, J.J. Van Wyk, and D.E. AJ. 1977. Estimation of somatomedin-C levels in normals and patients with pituitary disease by radioimmunoassay. J. Clin. Invest. 60:648-657.
24. Hirschberg, R., and J.D. Kopple. 1991. Response of insulin-like growth factor I and renal hemodynamics to a high- and low-protein diet in the rat. J. Am. Soc. Nephrol. 1:1034-1040.
25. Hossenlopp, P., D. Seurin, B. Segovia-Ouinson, S. Hardouin, and M. Binoux. 1986. Analysis of serum insulin-like growth factor binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal. Biochem. 154:138-143.
26. Hossenlopp, P., B. Segovia, C. Lassarre, M. Roghani, M. Bredon, and M. Binoux. 1990. Evidence of enzymatic degradation of insulin-like growth factor-binding proteins in the 150K complex during pregnancy. J. Clin. Endocrinol. & Metab. 71:797-805.
27. Thabet, M.A., A. Challa, W. Chan, F. Liu, R.L. Hintz, and J.C. Chan. 1994. Insulin-like growth factor and growth hormone receptor in nephrotic rats. Am. J. Physiol. 266:102-106.
28. Ziyadeh, F., Y. Jin, J. Guo, M. Ericksen, and K. Sharma. 1995. Up-regulation of type II TGF-B receptor mRNA by IGF-1 in proximal tubular cells: Role in diabetic renal hypertrophy. J. Am. Soc. Nephrol. 6:1053. (Abstr.)
29. Baxter, R.C. 1991. Insulin-like growth factor (IGF) binding proteins: the role of serum IGFBPs in regulating IGF availability. Acta Paediatr. Scand. Suppl. 372:107-114; Discussion 115.
30. Bourner, M., W. Busby, N. Seigel, G. Krivi, R. McCusker, and D. Clemmons. 1992. Cloning and sequence determination of bovine insulin-like growth factor binding protein-2 (IGFBP-2): comparison of its structural and functional properties with IGFBP-1. J. Cell Biochem. 48:215-226.
31. Reeve, J., J. Schwander, and N. Bleehen. 1993. IGFBP-2: an important regulator of insulin like growth factor action in human lung tumors. Growth Regulation. 3:82-84.
32. Ross, G., G. Francis, L. Szabo, J. Wallace, and F. Ballard. 1989. Insulin-like growth factor (IGF)-binding proteins inhibit the biological activities of IGF-1 and IGF-2 but not des-(1-3)-IGF-I. Biochem. J. 258:267-272.
33. Feyen, J., D. Evans, C. Binkert, G. Heinrich, S. Geisse, and H. Koeher. 1991. Recombinant human CYS 281 insulin like growth factor binding protein-2 inhibits both basal and insulin like growth factor I stimulated proliferation and collagen synthesis in fetal rat calvaria. J. Biol. Chem. 266:19469-19474.
34. Bach, L.A., S. Hsieh, K. Sakano, H. Fujiwara, J.F. Perdue, and M.M. Rechler. 1993. Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. J. Biol. Chem. 268:9246-9254.
35. Jones, C.L., S. Buch, M. Post, L. McCulloch, E. Liu, and A.A. Eddy. 1992. Renal extracellular matrix accumulation in acute puromycin aminonucleoside nephrosis in rats. Am. J. Pathol. 141:1381-1396.
36. Bader, R., H. Bader, K. E. Grund, S. Mackensen-Haen, H. Christ, and A. Bohle. 1980. Structure and function of the kidney in diabetic glomerulosclerosis. Correlations between morphological and functional parameters. Pathol. Res. Pract. 167:204-216.
37. Mackensen-Haen, S., R. Bader, K.E. Grund, and A. Bohle. 1981. Correlations between renal cortical interstitial fibrosis, atrophy of the proximal tubules and impairment of the glomerular filtration rate. Clin. Nephrol. 15:167-171.
38. Haen, M., S. Mackensen-Haen, T. Klingebiel, B. Stark-Jakob, H. Christ, and A. Bohle. 1985. Creatinine clearance and renal interstitium in diffuse endocapillary proliferative glomerulonephritis. Pathol. Res. Pract. 179:462-468.
39. Schmitt, H., V. Cavalcanti de Oliveira, and A. Bohle. 1987. Tubulointerstitial alterations in type I membranoproliferative glomerulonephritis. An investigation of 259 cases. Pathol. Res. Pract. 182:6-10.
40. Bohle, A., S. Mackensen-Haen, and H. von Gise. 1987. Significance of tubulointerstitial changes in the renal cortex for the excretory function and concentration ability of the kidney: a morphometric contribution. Am. J. Nephrol. 7:421-433.
41. Mackensen-Haen, S., R. Eissele, and A. Bohle. 1988. Contribution on the correlation between morphometric parameters gained from the renal cortex and renal function in IgA nephritis. Lab. Invest. 59:239-244.
42. Wehrmann, M., A. Bohle, O. Bogenschutz, R. Eissele, A. Freislederer, C, Ohlschlegel, G. Schumm, C. Batz, and H.V. Gartner. 1989. Long-term prognosis of chronic idiopathic membranous glomerulonephritis. An analysis of 334 cases with particular regard to tubulo-interstitial changes. Clin. Nephrol. 31:67-76.
43. Wehrmann, M., A. Bohle, H. Held, G. Schumm, H. Kendziorra, and H. Pressler. 1990. Long-term prognosis of focal sclerosing glomerulonephritis. An analysis of 250 cases with particular regard to tubulointerstitial changes. Clin. Nephrol. 33:115-122.
44. Bohle, A., M. Wehrmann, O. Bogenschutz, C. Batz, C.A. Muller, and G.A. Muller. 1991. The pathogenesis of chronic renal failure in diabetic nephropathy. Investigation of 488 cases of diabetic glomerulosclerosis. Pathol. Res. Pract. 187:251-259.
45. Mackensen-Haen, S., A. Bohle, J. Christensen, M. Wehrmann, H. Kendziorra, and F. Kokot. 1992. The consequences for renal function of widening of the interstitium and changes in the tubular epithelium of the renal cortex and outer medulla in various renal diseases. Clin. Nephrol. 37:70-77.
46. Bohle, A., M. Wehrmann, O. Bogenschutz, C. Batz, W. Vogl, H. Schmitt, C.A. Muller, and G.A. Muller. 1992. The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res. Pract. 188:908-924.
47. Milewski, C., M. Konig, H. von Gise, and A. Bohle. 1983. Clinical and morphological aspects of nephrotic syndrome in perimembranous, focally sclerosing and membrano-proliferative glomerulonephritis. Klin. Wochenschr. 61: 493-497.
48. Thomas, M.E., A.R. Morrison, and G.F. Schreiner. 1995. Metabolic effects of fatty acid-bearing albumin on a proximal tubule cell line. Am. J. Physiol. 268:1177-1184.
49. Thomas, M.E., and G.F. Schreiner. 1993. Contribution of proteinuria to progressive renal injury: consequences of tubular uptake of fatty acid bearing albumin. Am. J. Nephrol. 13:385-398.
50. Tamaki, K., S. Okuda, T. Ando, T. Iwamoto, M. Nakayama, and M. Fujishima. 1994. TGF-beta 1 in glomerulosclerosis and interstitial fibrosis of adriamycin nephropathy. Kidney Int. 45:5255-5236.
51. Creely, J.J., S.J. DiMari, A.M. Howe, and M.A. Haralson. 1992. Effects of transforming growth factor-beta on collagen synthesis by normal rat kidney epithelial cells. Am. J. Pathol. 140:45-55.